BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 38510818)

  • 1. Refractory Burkitt Lymphoma: Diagnosis and Interventional Strategies.
    Malfona F; Testi AM; Chiaretti S; Moleti ML
    Blood Lymphat Cancer; 2024; 14():1-15. PubMed ID: 38510818
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.
    Hagemeister FB
    Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeted therapy in Burkitt lymphoma: Small molecule inhibitors under investigation.
    Atallah-Yunes SA; Habermann TM; Khurana A
    Br J Haematol; 2024 Jun; 204(6):2165-2172. PubMed ID: 38577716
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical outcome of relapsed or refractory burkitt lymphoma and mature B-cell lymphoblastic leukemia in children and adolescents.
    Kim H; Park ES; Lee SH; Koo HH; Kim HS; Lyu CJ; Jun SE; Lim YT; Baek HJ; Kook H; Lee JW; Kang HJ; Park KD; Shin HY; Ahn HS
    Cancer Res Treat; 2014 Oct; 46(4):358-65. PubMed ID: 25043820
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Case Report: Unedited allogeneic chimeric antigen receptor T cell bridging to conditioning-free hematopoietic stem cell transplantation for a child with refractory Burkitt lymphoma.
    Yang X; Luo C; Qian J; Huang X; Zhang J; Wang J; Luo C; Qin X; Li B; Chen J
    Front Immunol; 2023; 14():1219872. PubMed ID: 37736096
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chimeric Antigen Receptor-Modified T Cell Immunotherapy for Relapsed and Refractory Adult Burkitt Lymphoma.
    Wu J; Cao Y; Zhang Q; Liu W; Zhou X; Ming X; Meng F; Zhang Y; Li C; Huang L; Wei J; Zheng M; Zhang S; Zhang T; Zhu X; Wang N; Wang J; Wang G; Zhou J; Liu B; Xiao Y
    Front Immunol; 2022; 13():879983. PubMed ID: 35669773
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extracorporeal photophoresis: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2006; 6(6):1-82. PubMed ID: 23074497
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of relapsed/refractory paediatric aggressive B-cell non-Hodgkin lymphoma.
    Moleti ML; Testi AM; Foà R
    Br J Haematol; 2020 Jun; 189(5):826-843. PubMed ID: 32141616
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relapsed/refractory Burkitt lymphoma and HIV infection.
    Khan A; Brahim A; Ruiz M; Nagovski N
    Int J STD AIDS; 2018 Jun; 29(7):695-703. PubMed ID: 29264956
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A case report of acquired immunodeficiency syndrome (AIDS)-related refractory Burkitt lymphoma got complete remission by multidisciplinary and multi-target combined therapy.
    Zhang R; Sun J
    Transl Cancer Res; 2022 Jun; 11(6):1806-1812. PubMed ID: 35836543
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relapsed/refractory pediatric B-cell non-Hodgkin lymphoma treated with rituximab combination therapy: A report from the Japanese Pediatric Leukemia/Lymphoma Study Group.
    Osumi T; Mori T; Fujita N; Saito AM; Nakazawa A; Tsurusawa M; Kobayashi R
    Pediatr Blood Cancer; 2016 Oct; 63(10):1794-9. PubMed ID: 27314926
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Primary refractory and relapsed adult acute lymphoblastic leukemia: characteristics, treatment results, and prognosis with salvage therapy.
    Thomas DA; Kantarjian H; Smith TL; Koller C; Cortes J; O'Brien S; Giles FJ; Gajewski J; Pierce S; Keating MJ
    Cancer; 1999 Oct; 86(7):1216-30. PubMed ID: 10506707
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Unusually swift response of relapsed Burkitt leukemia to R-DHAP.
    Harrer DC; Denk A; Keil F; Menhart K; Mayer S; Wolff D; Edinger M; Herr W; Grube M
    EJHaem; 2022 Aug; 3(3):1003-1008. PubMed ID: 36051076
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hematopoietic Cell Transplantation and Adoptive Cell Therapy in Peripheral T Cell Lymphoma.
    Rogers AM; Brammer JE
    Curr Hematol Malig Rep; 2020 Aug; 15(4):316-332. PubMed ID: 32529515
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sequential anti-CD19, 22, and 20 autologous chimeric antigen receptor T-cell (CAR-T) treatments of a child with relapsed refractory Burkitt lymphoma: a case report and literature review.
    Du J; Zhang Y
    J Cancer Res Clin Oncol; 2020 Jun; 146(6):1575-1582. PubMed ID: 32222815
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel Treatments of Adult T Cell Leukemia Lymphoma.
    El Hajj H; Tsukasaki K; Cheminant M; Bazarbachi A; Watanabe T; Hermine O
    Front Microbiol; 2020; 11():1062. PubMed ID: 32547515
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcomes in patients with aggressive B-cell non-Hodgkin lymphoma after intensive frontline treatment failure.
    Ayers EC; Li S; Medeiros LJ; Bond DA; Maddocks KJ; Torka P; Mier Hicks A; Curry M; Wagner-Johnston ND; Karmali R; Behdad A; Fakhri B; Kahl BS; Churnetski MC; Cohen JB; Reddy NM; Modi D; Ramchandren R; Howlett C; Leslie LA; Cytryn S; Diefenbach CS; Faramand R; Chavez JC; Olszewski AJ; Liu Y; Barta SK; Mukhija D; Hill BT; Ma H; Amengual JE; Nathan S; Assouline SE; Orellana-Noia VM; Portell CA; Chandar A; David KA; Giri A; Hess BT; Landsburg DJ
    Cancer; 2020 Jan; 126(2):293-303. PubMed ID: 31568564
    [TBL] [Abstract][Full Text] [Related]  

  • 18. EFFICACY OF AUTOLOGOUS STEM CELL TRANSPLANTATION IN ADULT BURKITT/BURKITT-LIKE LYMPHOMA: A SYSTEMATIC REVIEW.
    Joshi U; Subedi R; Nepal G; Gyawali S; Agrawal V; Poudyal BS; Bhatt VR; D'Angelo CR
    Exp Oncol; 2022 Nov; 44(3):190-197. PubMed ID: 36325697
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcome of relapse in children and adolescents with B-cell non-Hodgkin lymphoma and mature acute leukemia: A report from the French LMB study.
    Rigaud C; Auperin A; Jourdain A; Haouy S; Couec ML; Aladjidi N; Gandemer V; Lambliotte A; Plat G; Landman-Parker J; Michon J; Leblanc T; Patte C; Minard-Colin V
    Pediatr Blood Cancer; 2019 Sep; 66(9):e27873. PubMed ID: 31207026
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early relapse of Burkitt lymphoma heralded by a bone marrow necrosis and numb chin syndrome successfully treated with allogeneic stem cell transplantation.
    Cerny J; Devitt K; Yu H; Ramanathan M; Woda B; Nath R
    Leuk Res Rep; 2014; 3(2):51-3. PubMed ID: 25068102
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.